• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衰弱对老年房颤患者预后的影响:一项系统评价和荟萃分析。

Impact of frailty on outcomes of elderly patients with atrial fibrillation: A systematic review and meta-analysis.

作者信息

Yao Jianhong, Chen Ke, He Zhifen, Chen Dan

机构信息

Jianhong Yao, Department of Geriatric, Huzhou Third Municipal Hospital, Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province 313000, P.R. China.

Ke Chen, Department of Geriatric Psychiatry, Huzhou Third Municipal Hospital, Affiliated Hospital of Huzhou University, Huzhou, Zhejiang Province 313000, P.R. China.

出版信息

Pak J Med Sci. 2025 Mar;41(3):891-901. doi: 10.12669/pjms.41.3.11357.

DOI:10.12669/pjms.41.3.11357
PMID:40103904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11911724/
Abstract

OBJECTIVE

Atrial fibrillation (AF) prevalences have risen globally due to the increasing aging populations posing significant health challenges. Frailty, a state characterized by weak physiological reserves, has emerged as a crucial factor influencing cardiovascular disease outcomes, including those in patients with AF. With this systematic review and meta-analysis, we aimed to elucidate the impact of frailty on mortality, and the incidences of stroke, major bleeding events, and other outcomes in elderly patients with AF.

METHOD

A comprehensive search of PubMed, EMBASE, and Scopus databases yielded 1302 relevant records from inception until January 2024. We screened them to assess their eligibility for our study. We included data from 23 studies into our analysis, covering a diverse global population. We also assessed the quality of the included studies by assigning Newcastle- Ottawa Scale scores.

RESULTS

Frailty demonstrated a consistent association with increased all-cause mortality (Hazards ratio [HR] 2.46 in frail individuals). Frailty also correlated with elevated risks of stroke (HR, 1.46) and major bleeding events (HR, 1.34). Our analysis also revealed non-significant associations with cardiovascular death and intra-cranial hemorrhage.

CONCLUSION

Frailty significantly increases the frequency of adverse outcomes in elderly patients with AF; thus, these patients should be managed with tailored risk stratification tools. Integrating frailty assessments into clinical decision-making should aid in optimizing care strategies and enhance outcomes in this vulnerable population.

摘要

目的

由于全球人口老龄化加剧,心房颤动(AF)的患病率不断上升,这带来了重大的健康挑战。衰弱是一种以生理储备薄弱为特征的状态,已成为影响心血管疾病结局(包括AF患者)的关键因素。通过这项系统评价和荟萃分析,我们旨在阐明衰弱对老年AF患者死亡率、中风发生率、重大出血事件及其他结局的影响。

方法

对PubMed、EMBASE和Scopus数据库进行全面检索,从建库至2024年1月共获得1302条相关记录。我们对这些记录进行筛选,以评估其是否符合我们的研究要求。我们将23项研究的数据纳入分析,这些研究涵盖了不同的全球人群。我们还通过赋予纽卡斯尔-渥太华量表分数来评估纳入研究的质量。

结果

衰弱与全因死亡率增加存在一致关联(衰弱个体的风险比[HR]为2.46)。衰弱还与中风风险升高(HR,1.46)和重大出血事件风险升高(HR,1.34)相关。我们的分析还显示,衰弱与心血管死亡和颅内出血之间无显著关联。

结论

衰弱显著增加老年AF患者不良结局的发生率;因此,应对这些患者使用量身定制的风险分层工具进行管理。将衰弱评估纳入临床决策应有助于优化护理策略并改善这一脆弱人群的结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/522f37a6de61/PJMS-41-891-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/ee533d370d3b/PJMS-41-891-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/117d91afad3a/PJMS-41-891-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/06750b4dc530/PJMS-41-891-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/522f37a6de61/PJMS-41-891-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/ee533d370d3b/PJMS-41-891-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/117d91afad3a/PJMS-41-891-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/06750b4dc530/PJMS-41-891-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/11911724/522f37a6de61/PJMS-41-891-g004.jpg

相似文献

1
Impact of frailty on outcomes of elderly patients with atrial fibrillation: A systematic review and meta-analysis.衰弱对老年房颤患者预后的影响:一项系统评价和荟萃分析。
Pak J Med Sci. 2025 Mar;41(3):891-901. doi: 10.12669/pjms.41.3.11357.
2
Impact of frailty models on the prescription of oral anticoagulants and on the incidence of stroke, bleeding, and mortality in older patients with atrial fibrillation: a systematic review.衰弱模型对老年心房颤动患者口服抗凝药物的处方、卒中、出血和死亡率的影响:系统评价。
Ageing Res Rev. 2022 Dec;82:101761. doi: 10.1016/j.arr.2022.101761. Epub 2022 Oct 18.
3
Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: A meta-analysis.衰弱对房颤患者全因死亡率和主要出血事件的影响:一项荟萃分析。
Ageing Res Rev. 2022 Jan;73:101527. doi: 10.1016/j.arr.2021.101527. Epub 2021 Nov 26.
4
Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients.衰弱症在房颤患者中的患病率及其对结局的影响:一项纳入 118.7 万名患者的系统评价和荟萃分析。
Ageing Res Rev. 2022 Aug;79:101652. doi: 10.1016/j.arr.2022.101652. Epub 2022 May 31.
5
What is the Impact of Frailty on Prescription of Anticoagulation in Elderly Patients with Atrial Fibrillation? A Systematic Review and Meta-Analysis.衰弱对老年房颤患者抗凝治疗处方有何影响?一项系统评价和荟萃分析。
J Atr Fibrillation. 2018 Apr 30;10(6):1870. doi: 10.4022/jafib.1870. eCollection 2018 Apr.
6
Association of CHADS-VASc and HAS-BLED to frailty and frail outcomes: From the TREAT-AF study.CHADS-VASc 和 HAS-BLED 与虚弱和虚弱结局的关联:来自 TREAT-AF 研究。
Am Heart J. 2023 Jul;261:85-94. doi: 10.1016/j.ahj.2023.03.015. Epub 2023 Apr 5.
7
Impact of frailty on outcomes of elderly patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis.衰弱对接受经皮冠状动脉介入治疗的老年患者结局的影响:一项系统评价和荟萃分析。
World J Clin Cases. 2024 Jan 6;12(1):107-118. doi: 10.12998/wjcc.v12.i1.107.
8
Effectiveness and Safety of Anticoagulation Therapy in Frail Patients With Atrial Fibrillation.衰弱患者心房颤动抗凝治疗的有效性和安全性。
Stroke. 2022 Jun;53(6):1873-1882. doi: 10.1161/STROKEAHA.121.036757. Epub 2022 Feb 3.
9
Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial.在 ELDERCARE-AF 随机临床试验中,衰弱的房颤患者使用极低剂量依度沙班的结果和安全性。
JAMA Netw Open. 2022 Aug 1;5(8):e2228500. doi: 10.1001/jamanetworkopen.2022.28500.
10
Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes.衰弱和心房颤动对老年急性冠状动脉综合征患者的影响。
Eur J Clin Invest. 2021 May;51(5):e13505. doi: 10.1111/eci.13505. Epub 2021 Feb 12.

引用本文的文献

1
The Association Between Peripheral Arterial Disease and Long-Term Bleeding Events in Patients with Acute Myocardial Infarction.急性心肌梗死患者外周动脉疾病与长期出血事件之间的关联
J Clin Med. 2025 May 4;14(9):3183. doi: 10.3390/jcm14093183.

本文引用的文献

1
Impact of Frailty on Clinical Outcomes in Patients With Atrial Fibrillation Who Underwent Cardiac Ablation Using a Nationwide Database.基于全国数据库的研究:衰弱对接受心脏消融术的房颤患者临床结局的影响。
Am J Cardiol. 2023 Sep 15;203:98-104. doi: 10.1016/j.amjcard.2023.07.020. Epub 2023 Jul 22.
2
The impact of frailty on the management of atrial fibrillation.衰弱对心房颤动管理的影响。
Aging (Albany NY). 2023 Jul 19;15(14):6622-6624. doi: 10.18632/aging.204918.
3
Frailty and oral anticoagulant prescription in adults with atrial fibrillation: A systematic review.
房颤成人患者的衰弱与口服抗凝药处方:一项系统评价
Aging Med (Milton). 2022 Jun 1;6(2):195-206. doi: 10.1002/agm2.12214. eCollection 2023 Jun.
4
Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: The Shizuoka study.口服抗凝剂治疗的老年房颤患者的衰弱及随后的不良结局:静冈研究。
Res Pract Thromb Haemost. 2023 Mar 25;7(3):100129. doi: 10.1016/j.rpth.2023.100129. eCollection 2023 Mar.
5
The effect of frailty in older community-dwelling outpatients with atrial fibrillation: a new score HAS-BLED-F (rail).衰弱对老年社区门诊心房颤动患者的影响:新评分 HAS-BLED-F(rail)。
Eur Rev Med Pharmacol Sci. 2023 Apr;27(7):2919-2926. doi: 10.26355/eurrev_202304_31923.
6
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study.衰弱对非维生素 K 拮抗剂口服抗凝剂(NOACs)在房颤患者中的疗效和安全性的影响:一项全国性队列研究。
Eur Heart J Qual Care Clin Outcomes. 2024 Jan 12;10(1):55-65. doi: 10.1093/ehjqcco/qcad019.
7
Frailty and the Interactions between Skeletal Muscle, Bone, and Adipose Tissue-Impact on Cardiovascular Disease and Possible Therapeutic Measures.虚弱与骨骼肌、骨骼和脂肪组织之间的相互作用——对心血管疾病的影响及可能的治疗措施。
Int J Mol Sci. 2023 Feb 25;24(5):4534. doi: 10.3390/ijms24054534.
8
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments.衰老和与衰老相关的疾病:从分子机制到干预和治疗。
Signal Transduct Target Ther. 2022 Dec 16;7(1):391. doi: 10.1038/s41392-022-01251-0.
9
Differential effect of anticoagulation according to cognitive function and frailty in older patients with atrial fibrillation.抗凝治疗在老年房颤患者中的认知功能和虚弱程度的差异影响。
J Am Geriatr Soc. 2023 Feb;71(2):394-403. doi: 10.1111/jgs.18079. Epub 2022 Oct 23.
10
Multisystem physiological perspective of human frailty and its modulation by physical activity.人体脆弱性的多系统生理观点及其通过身体活动的调节。
Physiol Rev. 2023 Apr 1;103(2):1137-1191. doi: 10.1152/physrev.00037.2021. Epub 2022 Oct 14.